Severe acute respiratory syndrome - A new coronavirus from the Chinese dragon's lair

Scandinavian Journal of Immunology

Volumn 58, Issue 3, 2003, Pages 277-284

  Knudsen, T B ^a   Kledal, T N ^a   Andersen, O ^a   Eugen Olsen, J ^a   Kristiansen, T B ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; CHINESE; CLINICAL FEATURE; CORONAVIRUS; DIARRHEA; EPIDEMIC; FEVER; HUMAN; PATHOGENESIS; PHYSICIAN; POPULATION; PRIORITY JOURNAL; PUBLICATION; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS PNEUMONIA; VIRUS STRAIN;

CHINA; DISEASE OUTBREAKS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TRAVEL; WORLD HEALTH ORGANIZATION;

EID: 0041410010     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01302.x     Document Type: Review

References (35)

1. Donnelly CA, Ghani AC, Leung GM et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (Online) May 7, 2003.
2. WHO. Situation updates - severe acute respiratory syndrome (SARS) update 52 (available at: http://www.who.int).
3. Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
4. Booth CM, Matukas LM, Tomlinson GA et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 2003;289:2801-9.
5. Peiris JSM, Chu CM, Cheng VCC et al. Prospective study of the clinical progression and viral load of SARS associated coronavirus pneumonia in a community outbreak (accepted in Lancet and available at: http://www.who.int).
6. WHO. Situation updates - severe acute respiratory syndrome (SARS) update 49 (available at: http://www.who.int).
7. Drosten C, Günther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
8. Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
9. Tsang KW, Ho PL, Ooi GC et al. A cluster of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1977-85.
10. Poutanen SM, Low DE, Finkelstein S et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
11. Fouchier RA, Kuiken T, Schutten M et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
12. WHO. Situation updates - severe acute respiratory syndrome (SARS) update 64 (available at: http://www.who.int).
13. WHO. Situation updates - severe acute respiratory syndrome (SARS) update 47 (available at: http://www.who.int)
14. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161:158-16.
15. Nicolaou S, Al-Nakshabandi NA, Müller NL. SARS: Imaging of Severe Acute Respiratory Syndrome. Am J Roentgenol 2003;180:1247-9.
16. Armed Forces Institute of Pathology. http://www.afip.org/departments/Pulmonary/SARS/pathogen1b.html.
17. Nicholls JM, Poon LLM, Lee KC et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361 [epub ahead of print].
18. Fields BN, Knipe DM, Howley PM et al. Fields Virology, 2nd edn. Raven Press, 1990, 841-61.
19. Marra MA, Jones SJ, Astell CR et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
20. Rota PA, Oberste MS, Monroe SS et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
21. Peiris JS, Lai ST, Poon LL et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-25.
22. Delmas B, Gelfi J, L'Haridon R et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992;357:417-20.
23. Pasqualini R, Koivunen E, Kain R et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000;60:722-7.
24. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3Clpro) structure: basis for design of anti-SARS drugs. Science 2003;300:1763-7.
25. Saif LJ, Wesley R. Transmissible gastroenteritis virus. In: Straw BE, Allaire S, Mengeling WL, Taylor DJ, eds. Diseases of Swine, 8th edn. Ames, Iowa: Iowa State University Press, 1999, pp. 295-325.
26. Macnaughton MR, Hasony HJ, Madge MH, Reed SE. Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses. Infect Immun 1981;31:845-9.
27. Reed SE. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J Med Virol 1984;13:179-92.
28. Cavallaro JJ, Monto AS. Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh, Michigan. J Infect Dis 1970;122:272-9.
29. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalization among older adults. J Infect Dis 2002;185:1338-41.
30. Riski H, Hovi T. Coronavirus infections of man associated with diseases other than the common cold. J Med Virol 1980;6:259-65.
31. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with 'common cold' virus infections. Clin Infect Dis 2000;31:96-100.
32. McIntosh K, Chao Krause RK, Wasil HE, Mocega R, Mufson HE. Coronavirus infection in acute lower respiratory tract disease in infant. J Infect Dis 1974;130:502-7.
33. Hon LE, Leung Cheng WTF et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701-3.
34. Chadda K, Annane DK. The use of corticosteroids in severe sepsis and acute respiratory distress syndrome [Review]. Ann Med 2002;34:582-9.
35. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002;165:983-91.